Company intelligence / Profile preview
FUJIFILM Cellular Dynamics
- Ownership
- Private
- Employees
- ~220
- Development stage
- Other
Overview
FCDI has developed a robust iPSC platform for generating human cell types at scale. The company supplies these for research use worldwide and supports partners with cGMP manufacturing of clinical-grade iPSC-derived therapies. Its cardiovascular progenitor cell-derived extracellular vesicle product entered an investigator-sponsored clinical trial in non-ischemic heart failure in Europe. Other therapeutic areas are at preclinical or IND-enabling stages.
- Therapeutic areas
- OncologyCardiovascularOphthalmologyNeurology
- Modalities
- Induced pluripotent stem cell derived therapyCell therapyStem cell therapy
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on FUJIFILM Cellular Dynamics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FUJIFILM Cellular Dynamics.